Sort
8,912 grants matching “sars cov 2”
Computational mapping of human B cell migration and differentiation pathways
$249,000Kenneth Hoehn · Dartmouth College · R00 · FY2024 · AI
Understanding the immunometabolic response to Klebsiella pneumonia infection
$248,999Tania Wong Fok Lung · Rutgers Biomedical And Health Sciences · R00 · FY2024 · HL
Phenotypic and functional characterization of Betacoronavirus Internal protein in relation to virulence
$248,999Lok-Yin Roy Wong · Rutgers Biomedical And Health Sciences · R00 · FY2024 · AI
Role of mitochondrial/ER contacts in the regulation of mtDNA release from mitochondria, innate immune signaling, and responses to viral infection
$248,999Laura Elizabeth Newman · University Of Virginia · R00 · FY2024 · GM
Understanding the immunometabolic response to Klebsiella pneumonia infection
$248,999Tania Wong Fok Lung · Rutgers Biomedical And Health Sciences · R00 · FY2025 · HL
Innate immune factors governing restriction of human coronaviruses
$248,999Caitlin Stoddard · University Of Pittsburgh At Pittsburgh · R00 · FY2025 · AI
Phenotypic and functional characterization of Betacoronavirus Internal protein in relation to virulence
$248,999Lok-Yin Roy Wong · Rutgers Biomedical And Health Sciences · R00 · FY2025 · AI
Northern New England Clinical and Translational Research Network - Equipment
$248,974Clifford J Rosen · Mainehealth · U54 · FY2024 · GM
Role of Macrophages in CBD mediated attenuation of SEB-induced ARDS
$248,958Kiesha Wilson · University Of South Carolina At Columbia · R00 · FY2025 · GM
Role of Macrophages in CBD mediated attenuation of SEB-induced ARDS
$248,958Kiesha Wilson · University Of South Carolina At Columbia · R00 · FY2024 · GM
Role of Macrophages in CBD mediated attenuation of SEB-induced ARDS
$248,958Kiesha Wilson · University Of South Carolina At Columbia · R00 · FY2023 · GM
Mechanism of membrane inactivation method to prepare enveloped virus vaccines
$248,896Hector Aguilar-Carreno · Cornell University · R21 · FY2021 · AI
An urgently needed low-cost, rapidly deployable platform for simultaneous SARS-CoV-2 viral particle and COVID-19 IgG/IgM detection and quantification
$248,790Karthik Ratna Balakrishnan · Nodexus, Inc. · R43 · FY2020 · CA
In Vivo Cluster AI Prediction (CLAIRE) of COVID-19 Disease Progression
$248,723Patricia Buendia · Lifetime Omics, Inc. · R43 · FY2021 · EB
SBIR Phase I: Rapid, pre-symptomatic detection of COVID-19 and unknown viruses using a novel biosensor chip, computer vision and machine learning.
$248,706Stephen Turner · Nanocrine, Inc. · · FY2020 · TIP
Regulation of early life immunity by maternal microchimeric cells
$248,600Nitya Jain · Massachusetts General Hospital · R21 · FY2023 · AI
Reversing aging-induced lymphatic dysfunction to improve immune function
$248,600Timothy P Padera · Massachusetts General Hospital · R21 · FY2022 · AG
Development of a monoclonal therapy for neonatal herpes
$248,531Michael H Pauly · Zabbio, Inc. · R44 · FY2025 · AI
Immune response to COVID-19 vaccination in individuals with immune disorders
$248,499Steven Holland · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Clinical Core
$247,975Matthew Hamill · Johns Hopkins University · U54 · FY2025 · EB
Novel Hamster Models of Chikungunya Viral Arthritis
$247,852Tian Wang · University Of Texas Med Br Galveston · R21 · FY2024 · AI
Structural investigations of coronavirus spike protein
$247,750Syed Saif Hasan · University Of Maryland Baltimore · R21 · FY2024 · AI
Effects of SARS-CoV-2 Antiviral Ribonucleoside Analogues on Mitochondrial DNA
$247,746Alicia M Pickrell · Virginia Polytechnic Inst And St Univ · R21 · FY2022 · AI
Digital pathology for defining myeloid cell-mediated lung injury during acute SARS CoV-2 Infection in hamsters
$247,500Amanda Martinot · Tufts University Boston · R21 · FY2022 · AI
Nanobody toolkit for human coronavirus classification
$247,500Andrew Hayhurst · Texas Biomedical Research Institute · R21 · FY2022 · AI